EO 1301
Alternative Names: EO-1301Latest Information Update: 05 Apr 2021
At a glance
- Originator Emmecell
- Class Cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Macular degeneration